Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies1 [S]

D Tsiantoulas, T Perkmann, T Afonyushkin… - Journal of lipid …, 2015 - ASBMB
Oxidation-specific epitopes (OSEs) present on apoptotic cells and oxidized low density
lipoprotein (OxLDL) represent danger-associated molecular patterns that are recognized by …

Emerging therapies for the treatment of atherosclerotic cardiovascular disease: from bench to bedside

M Kumric, H Urlic, J Bozic, M Vilovic… - International journal of …, 2023 - mdpi.com
Primarily a consequence of sedentary lifestyle, atherosclerosis has already reached
pandemic proportions, and with every year the burden of it is only increasing. As low-density …

The emerging role of B lymphocytes in cardiovascular disease

L Adamo, C Rocha-Resende… - Annual review of …, 2020 - annualreviews.org
B cells are traditionally known for their ability to produce antibodies in the context of adaptive
immune responses. However, over the last decade B cells have been increasingly …

Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE−/− Mice

P Srikakulapu, D Hu, C Yin, SK Mohanta… - … , and vascular biology, 2016 - Am Heart Assoc
Objective—Explore aorta B-cell immunity in aged apolipoprotein E-deficient (ApoE−/−) mice.
Approach and Results—Transcript maps, fluorescence-activated cell sorting …

[HTML][HTML] Oxidized lipids: common immunogenic drivers of non-alcoholic fatty liver disease and atherosclerosis

C Hoebinger, D Rajcic, T Hendrikx - Frontiers in cardiovascular …, 2022 - frontiersin.org
The prevalence of non-alcoholic fatty liver disease (NAFLD), ranging from simple steatosis
to inflammatory steatohepatitis (NASH) and cirrhosis, continues to rise, making it one of the …

Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids

C Yeang, D Hasanally, X Que, MY Hung… - Cardiovascular …, 2019 - academic.oup.com
Aims Myocardial ischaemia followed by reperfusion (IR) causes an oxidative burst resulting
in cellular dysfunction. Little is known about the impact of oxidative stress on cardiomyocyte …

[HTML][HTML] Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease

T Yamashita, N Sasaki, K Kasahara, K Hirata - Journal of cardiology, 2015 - Elsevier
Atherosclerosis is believed to be a chronic inflammation of the arterial wall and various
immune cells of innate and adaptive immunity involves in the pathogenesis of …

Hypoxia-inducible factor prolyl 4-hydroxylase-2 inhibition protects against development of atherosclerosis

L Rahtu-Korpela, J Määttä, EY Dimova… - … and Vascular Biology, 2016 - Am Heart Assoc
Objective—Small-molecule hypoxia-inducible factor prolyl 4-hydroxylase (HIF-P4H)
inhibitors are being explored in clinical studies for the treatment of anemia. HIF-P4H-2 (also …

[HTML][HTML] Targeting foam cell formation to improve recovery from ischemic stroke

JC Zbesko, J Stokes, DA Becktel, KP Doyle - Neurobiology of Disease, 2023 - Elsevier
Inflammation is a crucial part of the healing process after an ischemic stroke and is required
to restore tissue homeostasis. However, the inflammatory response to stroke also worsens …

Germinal center–derived antibodies promote atherosclerosis plaque size and stability

M Centa, H Jin, L Hofste, S Hellberg, A Busch… - Circulation, 2019 - Am Heart Assoc
Background: Atherosclerosis progression is modulated by interactions with the adaptive
immune system. Humoral immunity can help protect against atherosclerosis formation; …